BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26987686)

  • 1. Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4(+) T-cell activation and dendritic cell maturation.
    Oliva H; Pacheco R; Martinez-Navio JM; Rodríguez-García M; Naranjo-Gómez M; Climent N; Prado C; Gil C; Plana M; García F; Miró JM; Franco R; Borras FE; Navaratnam N; Gatell JM; Gallart T
    Immunol Cell Biol; 2016 Aug; 94(7):689-700. PubMed ID: 26987686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells.
    Pido-Lopez J; Whittall T; Wang Y; Bergmeier LA; Babaahmady K; Singh M; Lehner T
    J Immunol; 2007 Feb; 178(3):1671-9. PubMed ID: 17237417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity.
    Pido-Lopez J; Wang Y; Seidl T; Babaahmady K; Vaughan R; Lehner T
    Eur J Immunol; 2009 Jul; 39(7):1956-65. PubMed ID: 19585516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.
    Pion M; Granelli-Piperno A; Mangeat B; Stalder R; Correa R; Steinman RM; Piguet V
    J Exp Med; 2006 Dec; 203(13):2887-93. PubMed ID: 17145955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells.
    Stopak KS; Chiu YL; Kropp J; Grant RM; Greene WC
    J Biol Chem; 2007 Feb; 282(6):3539-46. PubMed ID: 17110377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members.
    Huang J; Liang Z; Yang B; Tian H; Ma J; Zhang H
    J Biol Chem; 2007 Nov; 282(46):33632-33640. PubMed ID: 17848567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.
    Thielen BK; Klein KC; Walker LW; Rieck M; Buckner JH; Tomblingson GW; Lingappa JR
    PLoS Pathog; 2007 Sep; 3(9):1320-34. PubMed ID: 17892323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
    Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to apoptotic activated CD4+ T cells induces maturation and APOBEC3G-mediated inhibition of HIV-1 infection in dendritic cells.
    Mohanram V; Johansson U; Sköld AE; Fink J; Kumar Pathak S; Mäkitalo B; Walther-Jallow L; Spetz AL
    PLoS One; 2011; 6(6):e21171. PubMed ID: 21698207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.
    Chen K; Huang J; Zhang C; Huang S; Nunnari G; Wang FX; Tong X; Gao L; Nikisher K; Zhang H
    J Virol; 2006 Aug; 80(15):7645-57. PubMed ID: 16840343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.
    Koning FA; Newman EN; Kim EY; Kunstman KJ; Wolinsky SM; Malim MH
    J Virol; 2009 Sep; 83(18):9474-85. PubMed ID: 19587057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical fractionation and purification of high-molecular-mass APOBEC3G complexes.
    Chiu YL
    Methods Mol Biol; 2011; 718():185-206. PubMed ID: 21370050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.
    Chiu YL; Soros VB; Kreisberg JF; Stopak K; Yonemoto W; Greene WC
    Nature; 2005 May; 435(7038):108-14. PubMed ID: 15829920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells.
    Mohanram V; Sköld AE; Bächle SM; Pathak SK; Spetz AL
    J Immunol; 2013 Apr; 190(7):3346-53. PubMed ID: 23427247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.
    Khatua AK; Taylor HE; Hildreth JE; Popik W
    Virology; 2010 Apr; 400(1):68-75. PubMed ID: 20153011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity.
    Wang H; Zhong M; Li Y; Li K; Wu S; Guo T; Cen S; Jiang J; Li Z; Li Y
    Antiviral Res; 2019 May; 165():23-33. PubMed ID: 30862444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners.
    Zhao S; Zheng B; Wang L; Cui W; Jiang C; Li Z; Gao W; Zhang W
    Chin Med J (Engl); 2022 Nov; 135(22):2706-2717. PubMed ID: 36574218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.
    Trapp S; Derby NR; Singer R; Shaw A; Williams VG; Turville SG; Bess JW; Lifson JD; Robbiani M
    J Virol; 2009 Jan; 83(2):884-95. PubMed ID: 19004943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell agonists up-regulate AID and APOBEC3G deaminases, which induce IgA and IgG class antibodies and anti-viral function.
    Seidl T; Whittall T; Babaahmady K; Lehner T
    Immunology; 2012 Mar; 135(3):207-15. PubMed ID: 22044427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.
    Tiwarekar V; Wohlfahrt J; Fehrholz M; Scholz CJ; Kneitz S; Schneider-Schaulies J
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.